A new trading day began on Monday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price down -8.05% from the previous day of trading, before settling in for the closing price of $68.48. VKTX’s price has ranged from $9.34 to $99.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -6.59%. With a float of $107.93 million, this company’s outstanding shares have now reached $111.44 million.
The firm has a total of 27 workers. Let’s measure their productivity. In terms of profitability, gross margin is 28.9%, operating margin of -30726.61%, and the pretax margin is -22741.06%.
Viking Therapeutics Inc (VKTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 3.14%, while institutional ownership is 74.68%. The most recent insider transaction that took place on Nov 08 ’24, was worth 137,333. In this transaction Director of this company sold 2,000 shares at a rate of $68.67, taking the stock ownership to the 47,965 shares. Before that another transaction happened on Nov 08 ’24, when Company’s Director proposed sale 2,000 for $68.67, making the entire transaction worth $137,333.
Viking Therapeutics Inc (VKTX) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.25 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 36.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.51 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Analysing the last 5-days average volume posted by the [Viking Therapeutics Inc, VKTX], we can find that recorded value of 5.36 million was better than the volume posted last year of 4.51 million. As of the previous 9 days, the stock’s Stochastic %D was 23.96%. Additionally, its Average True Range was 5.07.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 47.33%, which indicates a significant increase from 13.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 116.47% in the past 14 days, which was higher than the 89.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $64.74, while its 200-day Moving Average is $61.13. Now, the first resistance to watch is $66.96. This is followed by the second major resistance level at $70.94. The third major resistance level sits at $73.02. If the price goes on to break the first support level at $60.90, it is likely to go to the next support level at $58.82. Should the price break the second support level, the third support level stands at $54.84.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
With a market capitalization of 6.98 billion, the company has a total of 111,436K Shares Outstanding. Currently, annual sales are 0 K while annual income is -85,900 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,940 K.
